Evidence map›Paper›PMID 35070987›Full record

ReviewFrontiers in oncology2021

The Interaction Between N

Lin Yao, Chang-Feng Man, Rong He, Lian He, Jia-Bin Huang, Shou-Yan Xiang, Zhe Dai, Xiao-Yan Wang, Yu Fan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. NJournal of cancer research and clinical oncology · 2023
    Article
  4. Article
  5. Novel insight into the functions of NInternational journal of oncology · 2022
    Review
  6. NCell death discovery · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lin YaoCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Chang-Feng ManCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Rong HeCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Lian HeCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Jia-Bin HuangCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Shou-Yan XiangCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Zhe DaiCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Xiao-Yan WangDigestive Department, The Affiliated Suqian first People's Hospital of Nanjing Medical University, Suqian, China.
Yu FanCancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Affiliated Hospital of Jiangsu University · CNJiangsu University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N

Indexed as

colorectal cancergastrointestinal tract cancerslong non-coding RNA (lncRNA)m6A modificationnon-coding RNAs (ncRNAs)

Identifiers

PMID35070987
PMCPMC8776638
OpenAlexW4206356553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.